TY - JOUR
T1 - A new classification of Diabetic Nephropathy 2014
T2 - a report from Joint Committee on Diabetic Nephropathy
AU - Haneda, Masakazu
AU - Utsunomiya, Kazunori
AU - Koya, Daisuke
AU - Babazono, Tetsuya
AU - Moriya, Tatsumi
AU - Makino, Hirofumi
AU - Kimura, Kenjiro
AU - Suzuki, Yoshiki
AU - Wada, Takashi
AU - Ogawa, Susumu
AU - Inaba, Masaaki
AU - Kanno, Yoshihiko
AU - Shigematsu, Takashi
AU - Masakane, Ikuto
AU - Tsuchiya, Ken
AU - Honda, Keiko
AU - Ichikawa, Kazuko
AU - Shide, Kenichiro
N1 - Publisher Copyright:
© 2014, Japanese Society of Nephrology, The Japan Diabetes Society, The Japanese Society for Dialysis Therapy, and Japan Society of Metabolism and Clinical Nutrition.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2015/2
Y1 - 2015/2
N2 - The Joint Committee on Diabetic Nephropathy has revised its Classification of Diabetic Nephropathy (Classification of Diabetic Nephropathy 2014) in line with the widespread use of key concepts such as the estimated glomerular filtration rate (eGFR) and chronic kidney disease. In revising the Classification, the Committee carefully evaluated, as relevant to current revision, the report of a study conducted by the Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan. Major revisions to the Classification are summarized as follows: (1) eGFR is substituted for GFR in the Classification; (2) the subdivisions A and B in stage 3 (overt nephropathy) have been reintegrated; (3) stage 4 (kidney failure) has been redefined as a GFR less than 30 mL/min/1.73 m2, regardless of the extent of albuminuria; and (4) stress has been placed on the differential diagnosis of diabetic nephropathy versus non-diabetic kidney disease as being crucial in all stages of diabetic nephropathy.
AB - The Joint Committee on Diabetic Nephropathy has revised its Classification of Diabetic Nephropathy (Classification of Diabetic Nephropathy 2014) in line with the widespread use of key concepts such as the estimated glomerular filtration rate (eGFR) and chronic kidney disease. In revising the Classification, the Committee carefully evaluated, as relevant to current revision, the report of a study conducted by the Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan. Major revisions to the Classification are summarized as follows: (1) eGFR is substituted for GFR in the Classification; (2) the subdivisions A and B in stage 3 (overt nephropathy) have been reintegrated; (3) stage 4 (kidney failure) has been redefined as a GFR less than 30 mL/min/1.73 m2, regardless of the extent of albuminuria; and (4) stress has been placed on the differential diagnosis of diabetic nephropathy versus non-diabetic kidney disease as being crucial in all stages of diabetic nephropathy.
KW - Albuminuria
KW - Chronic kidney disease (CKD)
KW - Diabetic nephropathy
KW - Glomerular filtration rate (GFR)
KW - Proteinuria
UR - http://www.scopus.com/inward/record.url?scp=85027951793&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027951793&partnerID=8YFLogxK
U2 - 10.1007/s10157-014-1057-z
DO - 10.1007/s10157-014-1057-z
M3 - Review article
C2 - 25527479
AN - SCOPUS:85027951793
VL - 19
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
SN - 1342-1751
IS - 1
ER -
